Leucovorin is a reduced form of folic acid, which has multiple uses.1 In this case report, it is used in combination with fluorouracil in the treatment of colon cancer. We describe a 53-year-old male, who was started on FOLFOX 6 + bevacizumab who experienced a hypersensitivity reaction to leucovorin. There have been very few cases of leucovorin hypersensitivity reactions reported in the literature. In this case, symptoms include flushing, hives, body pain, headaches, elevated blood pressures, and general discomfort. Although leucovorin reactions are considered rare, one should be aware of the types of reactions that can occur with leucovorin.
BenchalalMYahchouchy-ChouillardEFouereS. Anaphylactic shock secondary to intravenous administration of folinic acid: a first report. Ann Oncol2002; 13: 480–481.
2.
WaddellASolimandoD. Leucovorin, fluorouracil, and oxaliplatin (FOLFOX 6 and 7) regimens for colorectal cancer. Hosp Pharm2005; 40: 662–670, 736.
3.
LacyC. Drug information handbook, 19th ed. Hudson, OH: Lexi-Comp, 2010.
4.
SoulieresDGreerWMaglioccoM. KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies. Curr Oncol2010; 17: S31–S40.
5.
VermeulenCMathelier-FusadePGaouarH. Two cases of allergy to leucovorin. Rev fr’allergol2003; 43: 342–343.
6.
NaranjoCABustoUSellersEM. A method for estimating the probability of adverse drug reaction. Clin Pharmacol Ther1981; 30: 239–245.
